Evidence map›Paper›PMID 26854506›Full record

ArticleJournal of abnormal psychology2016

Developmental trajectories of clinically significant attention-deficit/hyperactivity disorder (ADHD) symptoms from grade 3 through 12 in a high-risk sample: Predictors and outcomes.

Tyler R Sasser, Carla B Kalvin, Karen L Bierman

Abstract read
In one paragraph

Article in Journal of abnormal psychology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tyler R SasserDepartment of Psychology, The Pennsylvania State University.
Carla B Kalvinof Psychology, The Pennsylvania State University.
Karen L Biermanof Psychology, The Pennsylvania State University.

Funding

Optimizing Prevention of Costly Adult OutcomesR01DA016903 · NIDA · DUKE UNIVERSITY · PI CROWLEY, DANIEL MAX, DODGE, KENNETH A · 2003 to 2019
$10.2M
Processes of Peer InfluenceP20DA017589 · NIDA · DUKE UNIVERSITY · PI STRAUMAN, TIMOTHY J · 2003 to 2007
$6.1M
MULTISITE PREVENTION OF CONDUCT PROBLEMSR18MH048043 · NIMH · DUKE UNIVERSITY · PI DODGE, KENNETH A · 1990 to 2002
$5.8M
MULTISITE PREVENTION OF CONDUCT DISORDERSR18MH050951 · NIMH · UNIVERSITY OF WASHINGTON · PI MCMAHON, ROBERT J. · 1993 to 2002
$3.7M
MULTISITE PREVENTION OF CONDUCT DISORDERR18MH050952 · NIMH · VANDERBILT UNIVERSITY · PI PINDERHUGHES, ELLEN E · 1993 to 2002
$3.7M
MULTISITE PREVENTION OF CONDUCT DISORDERR18MH050953 · NIMH · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI BIERMAN, KAREN L · 1993 to 2002
$3.5M
Adolescent Drug Use: Development, Prevention, and PolicyK05DA015226 · NIDA · DUKE UNIVERSITY · PI DODGE, KENNETH A · 2002 to 2012
$1.2M
RISK &PREVENTION OF CHILD DISRUPTIVE BEHAVIOR DISORDERSK05MH001027 · NIMH · VANDERBILT UNIVERSITY · PI DODGE, KENNETH A · 1992 to 2001
$200k
PREVENTION RESEARCH WITH AGGRESSIVE, REJECTED CHILDRENK05MH000797 · NIMH · DUKE UNIVERSITY · PI COIE, JOHN D · 1989 to 1998
–
NIDA NIH HHS DA015226NIDA NIH HHS DA017589NIDA NIH HHS DA16903NIDA NIH HHS K05 DA015226NIDA NIH HHS P20 DA017589NIDA NIH HHS R01 DA016903NIMH NIH HHS K05 MH000797NIMH NIH HHS K05 MH001027NIMH NIH HHS K05MH00797NIMH NIH HHS K05MH01027NIMH NIH HHS R18 MH048043NIMH NIH HHS R18 MH050951NIMH NIH HHS R18 MH050952NIMH NIH HHS R18 MH050953NIMH NIH HHS R18 MH48043NIMH NIH HHS R18 MH50951NIMH NIH HHS R18 MH50952NIMH NIH HHS R18 MH50953
6 · The paper itself

Abstract

Developmental trajectories of clinically significant attention-deficit/hyperactivity (ADHD) symptoms were explored in a sample of 413 children identified as high risk because of elevated kindergarten conduct problems. Symptoms of inattention and hyperactivity-impulsivity were modeled simultaneously in a longitudinal latent class analyses, using parent reports collected in Grades 3, 6, 9, and 12. Three developmental trajectories emerged: (1) low levels of inattention and hyperactivity (low), (2) initially high but then declining symptoms (declining), and (3) continuously high symptoms that featured hyperactivity in childhood and early adolescence and inattention in adolescence (high). Multinomial logistic regressions examined child characteristics and family risk factors as predictors of ADHD trajectories. Relative to the low class, children in the high and declining classes displayed similar elevations of inattention and hyperactivity in early childhood. The high class was distinguished from the declining class by higher rates of aggression and hyperactivity at school and emotion dysregulation at home. In contrast, the declining class displayed more social isolation at home and school, relative to the low class. Families of children in both high and declining trajectory classes experienced elevated life stressors, and parents of children in the high class were also more inconsistent in their discipline practices relative to the low class. By late adolescence, children in the high class were significantly more antisocial than those in the low class, with higher rates of arrests, school dropout, and unemployment, whereas children in the declining class did not differ from those in the low trajectory class. The developmental and clinical implications of these findings are discussed.

Indexed as

Adolescent DevelopmentChild DevelopmentAdolescentAttention Deficit Disorder with HyperactivityChildFemaleHumansMalePrognosis

Identifiers

PMID26854506
PMCPMC4747050

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.